Comparative analysis of laser ovarian drilling in surgical management of polycystic ovarian syndrome
Abstract
To assess the role of laparoscopic laser ovarian drilling in surgical management of polycystic ovary syndrome (PCOS) in comparison to other surgical techniques. The study involved 60 women diagnosed with polycystic ovary syndrome (clinical symptoms of the disease, as well as pelvic ultrasound scans and serum hormone levels, were assessed before and after surgery). Depending on the type of surgery, all patients were divided into groups: group № 1 (30 patients) underwent laparoscopic laser ovarian drilling using holmium laser, group № 2 (30 patients) underwent laparoscopic ovarian cautery using needle electrode. Group № 1 patients showed significantly higher rate of ovulation recovery and reproductive success in the program of assisted reproductive technologies (ART) when compared to group № 2 patients. When timely referred to the ART program after surgery, PCOS patients have a significantly higher chance of success in attaining and maintaining pregnancy. Ключевые слова. Синдром поликистозных яичников, лазерный дриллинг, гольмиевый лазер, электронож.
About the Authors
E. S. Aghajanyan
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
Ella S. Aghajanyan, Senior research fellow, Department of Obstetrics and Gynecology № 1
8-2, Trubetskaya, Moscow, 119991
A. I. Ishchenko
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Head of Department of Obstetrics and Gynecology № 1
Moscow
V. M. Zuev
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Department of Obstetrics and Gynecology № 1
Moscow
T. A. Dzhibladze
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Department of Obstetrics and Gynecology № 1
Moscow
References
1. Kulakov V.I., Leonova B.V., Kuzmicheva L.N. (eds). Treatment of male and female infertility. Moscow: MIA; 2005: 592 (in Russian).
2. Siristatidis C. et al. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction 2013. Cochrane Database Syst. Rev. 2013; Oct. 8: 10: CD006606. doi:10.1002/14651858.CD006606. pub 3.
3. Sirmans S., Pate K. Epidemiology, diagnosis and management of polycystic ovary syndrome. Clin. Epidemiol. 2013; Dec; 18: 61–13.
4. Drosdzol-Cop A. et al. Diagnosing polycystic ovary syndrome in adolescent girls. Ginekol. Pol. 2014; Feb; 85(2):145–148.
5. Azziz R. Controversy in clinical endocrinology: diagnosis of polycyctic ovarian syndrome: The Rotterdam criteria are premature. J. Clin. Endocrinol. Metab. 2006; 91: 781–785.
6. Norman R.J. et al. Polycyctic ovary syndrome. Lancet. 2007; 370: 685–697.
7. Setji T.L., Brown A.J. Polycystic ovary syndrome: update on diagnosis and treatment. Am. J. Med. 2014; May 21: S0002-9343(14)00356-8.
8. Levadas S., Diamanti-Kandarakis E. Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front Horm. Res. 2013; 40: 1–21.
9. Corbett S., Morin-Papunen L. The polycystic Ovary Syndrome and recent human evolution. Mol. Cell Endocrinol. 2013; Jul 5; 373(1–2): 39–50.
10. Abu Hashim H., Al-Inany H., De Vos M., Tournaye H. Three decades after Gjonnaess’s laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence –based approach. Arch. Gynecol. Obstet. 2013; Aug; 288(2): 409–422.
11. Pellatt L., Hanna L., Brincat M., Galea R., Brain H., Whitehead S., Mason H. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol Metab. 2007; Jan; 92(1): 240–245.
12. Pigny P., Jonard S., Robert Y., Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2006; Mar; 91(3): 941–945.
13. Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., Dewailly D. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J. Clin. Endocrinol. Metab. 2003; Dec; 88(12): 5957–5962.
14. Huber J., Hosmann J., Spona J. Polycystic ovarian syndrome treated by laser through the laparoscope. Lancet. 1988; 2: 215.
15. Daniell J.F., Miller W. Polycystic ovaries treated by laparoscopic laser vaporization. Fertil. Steril. 1989; 51: 232–236.
16. Van Wely M., Bayram N., van der Veen F., Bossuyt P.M. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod. 2012; Dec; 27(12): 3577–82.
17. Cohen J. Laparoscopic procedures for treatment of infertility related to polycystic ovarian syndrome. Hum. Reprod. Update. 1996; 2: 337–344.
18. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil and Steril. 2004; 81(1): 19–25.
19. Derkach D.A., Ponomarev T.A., Karpova E.A., Andreeva E.N. Surgical treatment of anovulation (review). Problems of reproduction. 2009; 2: 67–72 (in Russian).
20. Ishchenko A.I., Zuev V.M., Djibladze T.A. et al. Application of the holmium laser in operative gynecology. In: Textbook for interns and medical residents. 2008: 3–28 (in Russian).
21. Artini P.G. et al. Best methods for identification and treatment of PCOS. Minerva Ginecol. 2010; Feb; 62(1): 33–48.
22. Palomba S., Falbo A., Russo T., Zullo F. Ovulation induction in anovulatory patients with polycystic ovarian syndrome. Curr. Drug Ther. 2006; 1: 23–29.
23. Sheehan M.T. MD Polycystic Ovarian Syndrome: Diagnosis and Management. Clin. Med. Res. 2004; Feb; 2(1): 13–27.
24. Arbo E., Vetori D.V., Jimenez M.F. et al. Serum antimullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Human Reproduction. 2007; 22: 3192–3196.
25. Broer S., Mol B.W., Dolleman M. et al. The role of antiMullerian hormone assessment in assisted reproductive technology outcome. Curr. Opin. Obstet. Gynecol. 2010; 22: 193–201.
Review
Views:
276
Email this article 